A need for new converting enzyme inhibitors?
نویسندگان
چکیده
منابع مشابه
Angiotensin converting enzyme inhibitors.
The purpose of this brief review is to separate the characteristic properties and side effects attributable to the pharmacology of the whole class of angiotensin converting enzyme (ACE) inhibitors from those attributable to the chemical structure and kinetics of each particular ACE inhibitor. The former would be predictable and probably similar for all agents and, therefore, would be expected t...
متن کاملAngiotensin-converting enzyme inhibitors.
ACE inhibitors have achieved widespread usage in the treatment of cardiovascular and renal disease. ACE inhibitors alter the balance between the vasoconstrictive, salt-retentive, and hypertrophic properties of angiotensin II (Ang II) and the vasodilatory and natriuretic properties of bradykinin and alter the metabolism of a number of other vasoactive substances. ACE inhibitors differ in the che...
متن کاملAngiotensin-converting enzyme inhibitors: a new mechanism of action.
BACKGROUND Angiotensin-converting enzyme (ACE) inhibitors are valuable agents for the treatment of hypertension, heart failure, and other cardiovascular and renal diseases. The cardioprotective effects of ACE inhibitors are mediated by blockade of both conversion of angiotensin (Ang) I to Ang II and kinin hydrolysis. Here, we report a novel mechanism that may explain the cardiac antifibrotic ef...
متن کاملWS 75624 A and B , New Endothelin Converting Enzyme Inhibitors
mental analysis1} and high resolution fast atom bombardment MS (HRFAB-MS)1* and 13C NMRspectral data (Table 1). All 18 carbon signals were seen in the 13G NMRspectrum, consisting of one methyl, 5 CH2, 2 methoxy, one oxymethine, 2 =CH and 7 sp2 quaternary carbons. These groups accounted 22 non-exchangeable protons and therefore 2A possesses 2 exchangeable protons. It reacted quickly with trimeth...
متن کاملAngiotensin-Converting Enzyme Inhibitors and Active Tuberculosis
Numerous epidemiological data suggest that the use of angiotensin-converting enzyme inhibitors (ACEis) can improve the clinical outcomes of pneumonia. Tuberculosis (TB) is an airborne bacteria like pneumonia, and we aimed to find out whether the use of ACEis can decrease the risk of active TB.We conducted a nested case-control analysis by using a 1 million longitudinally followed cohort, from T...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1985
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.290.6463.180